Baird Financial Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-21,439
| Closed | -$21K | – | 1530 |
|
|
2019
Q3 | $21K | Sell |
21,439
-6,350
| -23% | -$6.22K | ﹤0.01% | 1499 |
|
|
2019
Q2 | $31K | Hold |
27,789
| – | – | ﹤0.01% | 1516 |
|
|
2019
Q1 | $36K | Buy |
27,789
+6,168
| +29% | +$7.99K | ﹤0.01% | 1280 |
|
|
2018
Q4 | $20K | Sell |
21,621
-3,092
| -13% | -$2.86K | ﹤0.01% | 1261 |
|
|
2018
Q3 | $49K | Buy |
24,713
+117
| +0.5% | +$232 | ﹤0.01% | 1319 |
|
|
2018
Q2 | $44K | Hold |
24,596
| – | – | ﹤0.01% | 1271 |
|
|
2018
Q1 | $58K | Hold |
24,596
| – | – | ﹤0.01% | 1240 |
|
|
2017
Q4 | $46K | Hold |
24,596
| – | – | ﹤0.01% | 1254 |
|
|
2017
Q3 | $61K | Sell |
24,596
-117
| -0.5% | -$290 | ﹤0.01% | 1222 |
|
|
2017
Q2 | $68K | Hold |
24,713
| – | – | ﹤0.01% | 1212 |
|
|
2017
Q1 | $75K | Buy |
24,713
+4,115
| +20% | +$12.5K | ﹤0.01% | 1204 |
|
|
2016
Q4 | $65K | Hold |
20,598
| – | – | ﹤0.01% | 1183 |
|
|
2016
Q3 | $70K | Hold |
20,598
| – | – | ﹤0.01% | 1182 |
|
|
2016
Q2 | $52K | Hold |
20,598
| – | – | ﹤0.01% | 1184 |
|
|
2016
Q1 | $52K | Sell |
20,598
-1,730
| -8% | -$4.37K | ﹤0.01% | 1203 |
|
|
2015
Q4 | $74K | Buy |
22,328
+6,840
| +44% | +$22.7K | ﹤0.01% | 1216 |
|
|
2015
Q3 | $38K | Buy |
15,488
+2,478
| +19% | +$6.08K | ﹤0.01% | 1234 |
|
|
2015
Q2 | $38K | Buy |
+13,010
| New | +$38K | ﹤0.01% | 1297 |
|